Group One Trading
AQST icon

Group One Trading’s Aquestive Therapeutics AQST Stock Holding History

Group One Trading’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74M Buy
659,800
+279,800
+74% +$1.14M 0.01% 1796
2025
Q4 		$2.45M Buy
380,000
+118,300
+45% +$737K ﹤0.01% 2099
2025
Q3 		$1.46M Buy
261,700
+160,900
+160% +$696K ﹤0.01% 2634
2025
Q2 		$334K Buy
100,800
+15,100
+18% +$43.3K ﹤0.01% 3814
2025
Q1 		$249K Buy
85,700
+78,900
+1,160% +$239K ﹤0.01% 3783
2024
Q4 		$24.2K Sell
6,800
-196,000
-97% -$904K ﹤0.01% 5570
2024
Q3 		$1.01M Buy
202,800
+5,600
+3% +$21.8K ﹤0.01% 2282
2024
Q2 		$513K Sell
197,200
-115,600
-37% -$386K ﹤0.01% 2541
2024
Q1 		$1.33M Buy
312,800
+282,400
+929% +$940K 0.01% 1826
2023
Q4 		$61.4K Sell
30,400
-60,500
-67% -$107K ﹤0.01% 4903
2023
Q3 		$139K Buy
90,900
+21,400
+31% +$36.8K ﹤0.01% 4130
2023
Q2 		$115K Buy
+69,500
New +$126K ﹤0.01% 4483
2022
Q4 		– Sell
-14,000
Closed -$16K – 7184
2022
Q3 		$16K Buy
+14,000
New +$15.8K ﹤0.01% 6205
2022
Q2 		– Sell
-67,100
Closed -$175K – 7755
2022
Q1 		$175K Buy
67,100
+39,400
+142% +$115K ﹤0.01% 4938
2021
Q4 		$108K Sell
27,700
-36,300
-57% -$182K ﹤0.01% 5665
2021
Q3 		$279K Buy
64,000
+42,200
+194% +$165K ﹤0.01% 4818
2021
Q2 		$87K Sell
21,800
-3,300
-13% -$13.2K ﹤0.01% 6093
2021
Q1 		$131K Buy
25,100
+12,500
+99% +$66.5K ﹤0.01% 5405
2020
Q4 		$67K Sell
12,600
-5,000
-28% -$30K ﹤0.01% 4817
2020
Q3 		$85K Buy
17,600
+7,500
+74% +$49K ﹤0.01% 4297
2020
Q2 		$49K Buy
+10,100
New +$46.5K ﹤0.01% 4369

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's AQST Position: Q3 2025 in Review

Group One Trading sold out of Aquestive Therapeutics (AQST) in Q3 2025, closing a stake of 12,185 shares — an estimated $52.7K sold.

Group One Trading first reported a position in AQST in Q2 2020 and held it in 16 quarters. The position peaked at $297K in Q4 2021. 152 funds tracked by Wall St. Rank hold AQST as of Q3 2025.

  • Group One Trading reported no remaining Aquestive Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 12,185 Aquestive Therapeutics shares in Q3 2025, an estimated $52.7K.
  • Group One Trading first reported a position in Aquestive Therapeutics in Q2 2020 and held it in 16 quarters.
  • Group One Trading's Aquestive Therapeutics position peaked at $297K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.